Peter C. Adamson, MD
Children’s Hospital of Philadelphia; Philadelphia, PA – Children’s Oncology Group – Chair; Chief, Division of Clinical Pharmacology & Therapeutics
Dr. Adamson’s laboratory focuses on the clinical pharmacology of new drugs for childhood cancer. His primary research focus has been on pediatric cancer drug development, specifically early phase clinical trials and clinical pharmacologic studies. In January of 2011, he became Chair of the Children’s Oncology Group (COG), a National Cancer Institute supported consortium of more than 220 centers across North America, Australia, New Zealand and parts of Europe, which conducts clinical-translational research including large-scale clinical trials in children with cancer. Previously he served as Chair of the COG’s Developmental Therapeutics Program. Other key roles that he has served in include Director of the Office for Clinical and Translational Research at The Children’s Hospital of Philadelphia, co-Director of the University of Pennsylvania CHOP Clinical Translational Science Award (CTSA), Program Director of the General Clinical Research Center (GCRC) and Principal Investigator of its NICHD funded Pediatric Pharmacology Research Unit (PPRU).